Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats.

These studies, together with our previous studies of Saz-A, revealed a spectrum of efficacies for these α4β2 nicotinic receptor desensitizing agents and provide a path forward for the most effective compounds to be further developed as possible aids to smoking cessation.